Structuring projects - SATT
Within the Institute Charles Gerhardt Montpellier, nine innovative research projects which bring new technologies in the Materials Chemistry and Processes, and Health and Biotechnologies fields, are supported by the Société d’Accélération du Transfert de Technologies (SATT AxLR).
Molecular and Macromolecular Chemistry Department of ICGM:
- Photon DROP project (IAM - J. Pinaud)
- GREENGENERIC project (AM²N - M. Taillefer)
- Magnetic gaz sensor project (IMNO - F. Terki)
- Innovative magnetic sensor project (IMNO - F. Terki)
- Green tech composite project (IAM - JP Habas)
- Phost'in (AM²N - JL Pirat et D. Virieux )
Department of Solid State and Divided Matter Chemistry of ICGM:
- Innovative material for lithium-ion batteries project (AIME - L. Monconduit)
- ION EX project (AIME - B. Prelot)
- New composites electrodes for Hydrogen/Oxygen electrolysers (AIME - F. Favier)
To know more about SATT AxLR
Since its creation, the Institute Charles Gerhardt Montpellier supports young innovative companies, in the fields of Energy, Health and Environment. For some years now, the ICGM has developed an industrial and scientific partnership with several companies.
Atheor is an authentication and traceability specialist which has developed an innovative glass marking technology.
Its originality lies in a process that uses soft chemistry, without energy and at room temperature. The product is based on a patented technology developed in an industrial and scientific partnership with the ICGM Architectures Moléculaires et Matériaux Nanostructurés (AM2N) research team.
Atheor's objective is to find solutions to the tracking issues and to : marking, batch number, validity date.
Product marking must satisfy:
- The regulations of the Visible, readable and indelible.
- The production traceability: mix of products, cross contaminations.
- The reliable traceability: anti-counterfeit and parallel markets.
- The quality traceability: cold chain control and storage, time-temperature indicator.
The main markets targeted by Atheor:
- Pharmaceutical: pharmaceutical bottles, light bulbs.
- Cosmetic: glass containers.
- Agribusiness: glass bottles.
- Tableware: glasses, crystal.
SiKÉMIA is a young society specialized in the field of materials surface functionalization: glass, metals, alloys, metal oxydes.
Developed through a partnership between several members of the ICGM research team Chimie Moléculaire et Organisation du Solide (CMOS), its products and services correspond to the outsourcing needs of the large industrial groups and are considered as a R&D center for the PME/PMI.
SiKÉMIA offers an appropriate method which gathers the development of innovative strengthen agents with the surface functionalization by chemical means. This approach gives a wide range of surface and substrates functionalities, with greater success than all the other techniques combined.
SiKÉMIA offers products and services at three levels:
- Products: A Catalog of 200 Innovative Organosilyl and Organophosphorous compounds from gram to ton
- Services: Research Contract including
- Custom Synthesis (Assessment for one original compound or an original compound group in silicon, phosphorus and sulfur chemistry)
- Development of Functionalized Surfaces (Functionalization and grafting study)
- Bibliographic survey and expertise for synthesis and/or grafting of coupling agents
Specific Polymers takes action in three main areas:
- Polymers Ingineering, for which it develops and files patents on chemical compounds in the field of specific polymers additives (cosmetics, nuclear energy, technical painting, technical textile, food packaging, release coating).
- The collaborative relationships R&D preparing studies to develop research on polymers and macromolecular materials for large industrial high-tech companies.
The production of innovative compounds produced by Specific Polymers, ensuring the "scale-up" and the industrial development.
Phost’In was born out of the union between the researchers - biologists and chemists - and clinicians internationally recognized for the gliomaargeted therapy. The project is built around a clinical specific need: the development of a family of small-sized innovative anticancer molecules to prohibit recidivism and metastasis in the case of highly aggressive cancers.
An anti-tumor and anti-migration treatment allowing to contain the tumor for improving the operability and to improve survival. The first in-man clinical trials are planned for 2017.
Phost'in works in close collaboration with both the ICGM research teams "Architectures Moléculaires et Matériaux Nanostructurés" (AM2N) and "Matériaux Avancés pour la Catalyse et la Santé" (MACS).
NanoMedSyn is a young biotechnology company created in 2012. It results from a collaboration between the ICGM research team "Chimie Moléculaire et Organisation du Solide" (CMOS), today divided into two research teams "Ingénierie Moléculaire et Nano-Objets" (IMNO) from ICGM and "Glyco et Nano Vecteurs pour le Ciblage Thérapeutique" from IBMM. It is composed by a dozen of researchers with complementary specialities.
Specialized in the development of novel molecules to be used in therapy targeting, NanoMedSyn has developed a molecule corresponding to the specific needs of lysosomal treatments. It develops a new therapeutic approach for orphan diseases and cancer treatment thanks to the development of molecules promoting cellular targeting and penetration.
The technology platform developed by NanoMedSyn consists in a combination of enzymes of substitution together with a compound created in order to improve the efficiency and the tolerance of these enzymes.